

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.99486740 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.99486740 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.81530715 |
| 4 | negative T cell selection (GO:0043383) | 5.68905392 |
| 5 | negative thymic T cell selection (GO:0045060) | 5.59812769 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.49839689 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.45630018 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.41905146 |
| 9 | thymic T cell selection (GO:0045061) | 5.15818927 |
| 10 | positive thymic T cell selection (GO:0045059) | 5.08135921 |
| 11 | T cell migration (GO:0072678) | 5.01218975 |
| 12 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.99130160 |
| 13 | response to interleukin-15 (GO:0070672) | 4.93143652 |
| 14 | cellular response to interleukin-15 (GO:0071350) | 4.86428361 |
| 15 | tolerance induction (GO:0002507) | 4.81809056 |
| 16 | T cell selection (GO:0045058) | 4.78162649 |
| 17 | interferon-gamma production (GO:0032609) | 4.54893405 |
| 18 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.50182652 |
| 19 | positive T cell selection (GO:0043368) | 4.49788336 |
| 20 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.49732032 |
| 21 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.43913490 |
| 22 | leukocyte aggregation (GO:0070486) | 4.36969541 |
| 23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.26965454 |
| 24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.26463058 |
| 25 | negative regulation of cell killing (GO:0031342) | 4.26463058 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.25204858 |
| 27 | neutrophil activation involved in immune response (GO:0002283) | 4.23260679 |
| 28 | B cell homeostasis (GO:0001782) | 4.21113059 |
| 29 | positive regulation of immunoglobulin production (GO:0002639) | 4.18644408 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.15757458 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 4.15757458 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 4.15757458 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 4.15757458 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.15757458 |
| 35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.15757458 |
| 36 | regulation of B cell differentiation (GO:0045577) | 4.14348513 |
| 37 | B cell receptor signaling pathway (GO:0050853) | 4.06237678 |
| 38 | regulation of B cell proliferation (GO:0030888) | 4.05960242 |
| 39 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.05644573 |
| 40 | T cell costimulation (GO:0031295) | 4.00344079 |
| 41 | regulation of gamma-delta T cell activation (GO:0046643) | 3.97630291 |
| 42 | lymphocyte costimulation (GO:0031294) | 3.96865279 |
| 43 | response to type I interferon (GO:0034340) | 3.89759497 |
| 44 | type I interferon signaling pathway (GO:0060337) | 3.87522548 |
| 45 | cellular response to type I interferon (GO:0071357) | 3.87522548 |
| 46 | regulation of T cell tolerance induction (GO:0002664) | 3.83823245 |
| 47 | immunoglobulin mediated immune response (GO:0016064) | 3.81736670 |
| 48 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.71448453 |
| 49 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.70300360 |
| 50 | T cell receptor signaling pathway (GO:0050852) | 3.66049190 |
| 51 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.65940836 |
| 52 | positive regulation of B cell proliferation (GO:0030890) | 3.65388081 |
| 53 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.64561344 |
| 54 | regulation of immunoglobulin production (GO:0002637) | 3.63063791 |
| 55 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.62492059 |
| 56 | detection of bacterium (GO:0016045) | 3.61870039 |
| 57 | B cell mediated immunity (GO:0019724) | 3.61650225 |
| 58 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.59448982 |
| 59 | negative regulation of B cell proliferation (GO:0030889) | 3.59080079 |
| 60 | positive regulation of B cell differentiation (GO:0045579) | 3.58047524 |
| 61 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.56840858 |
| 62 | regulation of response to interferon-gamma (GO:0060330) | 3.56513710 |
| 63 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.52391059 |
| 64 | cellular extravasation (GO:0045123) | 3.51650466 |
| 65 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.51541530 |
| 66 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.50707041 |
| 67 | positive regulation of isotype switching (GO:0045830) | 3.49264889 |
| 68 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.47338434 |
| 69 | positive regulation of interleukin-2 production (GO:0032743) | 3.46176761 |
| 70 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.44217989 |
| 71 | mature B cell differentiation (GO:0002335) | 3.42720395 |
| 72 | positive regulation of B cell activation (GO:0050871) | 3.42707550 |
| 73 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.40580895 |
| 74 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.39968856 |
| 75 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.39968856 |
| 76 | detection of other organism (GO:0098543) | 3.39554079 |
| 77 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.38934242 |
| 78 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.37622078 |
| 79 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.37622078 |
| 80 | megakaryocyte development (GO:0035855) | 3.37238028 |
| 81 | regulation of B cell activation (GO:0050864) | 3.36977822 |
| 82 | lymphocyte homeostasis (GO:0002260) | 3.36540729 |
| 83 | signal peptide processing (GO:0006465) | 3.35896360 |
| 84 | thrombin receptor signaling pathway (GO:0070493) | 3.35460376 |
| 85 | NIK/NF-kappaB signaling (GO:0038061) | 3.35439288 |
| 86 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.29672863 |
| 87 | positive regulation of humoral immune response (GO:0002922) | 3.29666129 |
| 88 | response to protozoan (GO:0001562) | 3.28408563 |
| 89 | defense response to protozoan (GO:0042832) | 3.26791513 |
| 90 | regulation of platelet aggregation (GO:0090330) | 3.26042915 |
| 91 | positive regulation of granulocyte differentiation (GO:0030854) | 3.24723726 |
| 92 | response to muramyl dipeptide (GO:0032495) | 3.24224480 |
| 93 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.19924124 |
| 94 | positive regulation of mast cell activation (GO:0033005) | 3.19484305 |
| 95 | negative regulation of T cell mediated immunity (GO:0002710) | 3.19463227 |
| 96 | response to host immune response (GO:0052572) | 3.17865693 |
| 97 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.17865693 |
| 98 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.16273899 |
| 99 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.16001653 |
| 100 | cytidine metabolic process (GO:0046087) | 3.15530518 |
| 101 | cytidine catabolic process (GO:0006216) | 3.15530518 |
| 102 | cytidine deamination (GO:0009972) | 3.15530518 |
| 103 | regulation of B cell mediated immunity (GO:0002712) | 3.15232292 |
| 104 | cellular response to interferon-beta (GO:0035458) | 3.14774360 |
| 105 | positive regulation of tolerance induction (GO:0002645) | 3.14610758 |
| 106 | natural killer cell activation (GO:0030101) | 3.14066174 |
| 107 | leukocyte cell-cell adhesion (GO:0007159) | 3.13287891 |
| 108 | regulation of interferon-alpha production (GO:0032647) | 3.13154489 |
| 109 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.12932122 |
| 110 | myeloid dendritic cell activation (GO:0001773) | 3.09355563 |
| 111 | neutrophil activation (GO:0042119) | 3.09123734 |
| 112 | cellular response to zinc ion (GO:0071294) | 3.09061013 |
| 113 | regulation of isotype switching (GO:0045191) | 3.08938930 |
| 114 | regulation of tolerance induction (GO:0002643) | 3.08037455 |
| 115 | mast cell activation (GO:0045576) | 3.07542154 |
| 116 | positive regulation of interleukin-4 production (GO:0032753) | 3.07488210 |
| 117 | germinal center formation (GO:0002467) | 3.06891324 |
| 118 | positive regulation of DNA recombination (GO:0045911) | 3.05935784 |
| 119 | B cell proliferation (GO:0042100) | 3.04877826 |
| 120 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.02782357 |
| 121 | T cell lineage commitment (GO:0002360) | 3.02759457 |
| 122 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.01364992 |
| 123 | positive regulation of B cell mediated immunity (GO:0002714) | 2.99842948 |
| 124 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.99842948 |
| 125 | myeloid dendritic cell differentiation (GO:0043011) | 2.99766773 |
| 126 | activated T cell proliferation (GO:0050798) | 2.99399116 |
| 127 | positive regulation of macrophage differentiation (GO:0045651) | 2.99392568 |
| 128 | T cell differentiation involved in immune response (GO:0002292) | 2.99055523 |
| 129 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.99055523 |
| 130 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.99055523 |
| 131 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.98971212 |
| 132 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.98888643 |
| 133 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.97553219 |
| 134 | negative regulation of interleukin-12 production (GO:0032695) | 2.97456326 |
| 135 | T cell activation involved in immune response (GO:0002286) | 2.92454906 |
| 136 | regulation of regulatory T cell differentiation (GO:0045589) | 2.92232691 |
| 137 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.91694329 |
| 138 | response to host (GO:0075136) | 2.90719996 |
| 139 | response to host defenses (GO:0052200) | 2.90719996 |
| 140 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.90719996 |
| 141 | myeloid cell activation involved in immune response (GO:0002275) | 2.90641745 |
| 142 | leukocyte homeostasis (GO:0001776) | 2.90164832 |
| 143 | lymphocyte migration (GO:0072676) | 2.90010621 |
| 144 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.89962654 |
| 145 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.89200624 |
| 146 | regulation of podosome assembly (GO:0071801) | 2.88660278 |
| 147 | positive regulation of interleukin-12 production (GO:0032735) | 2.87491322 |
| 148 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.86236333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.44155858 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.70726151 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.67558503 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.31867259 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.92475238 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.76454764 |
| 7 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.75401864 |
| 8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.47080628 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 3.27229987 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.22219989 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.19046057 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 3.08832761 |
| 13 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.00864798 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.95783171 |
| 15 | * MAF_26560356_Chip-Seq_TH1_Human | 2.93780966 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.65318368 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.64983327 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.59875165 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.58383590 |
| 20 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.31972068 |
| 21 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.31843136 |
| 22 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31358569 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.28115739 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.26597167 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.26591534 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19273704 |
| 27 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14126528 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07384566 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.05955186 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.05263014 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01854938 |
| 32 | MAF_26560356_Chip-Seq_TH2_Human | 1.97956622 |
| 33 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.96067087 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.95134802 |
| 35 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.93946996 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.85856736 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83771858 |
| 38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.81713088 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.76734434 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.73539183 |
| 41 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.69931248 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66384742 |
| 43 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.62299972 |
| 44 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.60082069 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.57332077 |
| 46 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.56898155 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.56389967 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.56031003 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.54229989 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53680493 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50793203 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.45664436 |
| 53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.41013536 |
| 54 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.37031822 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35261487 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35144985 |
| 57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.33940693 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27885788 |
| 59 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25617953 |
| 60 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23579721 |
| 61 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.22003992 |
| 62 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18006242 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17835684 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16450900 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14392847 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13174426 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12796604 |
| 68 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.12663442 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12263116 |
| 70 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10094193 |
| 71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09800815 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04960781 |
| 73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04075414 |
| 74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03151796 |
| 75 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02833689 |
| 76 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.01309749 |
| 77 | GATA1_22025678_ChIP-Seq_K562_Human | 1.00963129 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99664968 |
| 79 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99296853 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98819736 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96428734 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96286863 |
| 83 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95243591 |
| 84 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95195176 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93458931 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91152323 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89640408 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89210790 |
| 89 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88457234 |
| 90 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86282544 |
| 91 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.84937295 |
| 92 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84488370 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84351500 |
| 94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84190001 |
| 95 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82366630 |
| 96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81791030 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80778996 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78856596 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77677332 |
| 100 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.77525559 |
| 101 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.77296582 |
| 102 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76689640 |
| 103 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.76594164 |
| 104 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.76436415 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71877880 |
| 106 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.71748431 |
| 107 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71641231 |
| 108 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.70920854 |
| 109 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.69449234 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.69240776 |
| 111 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.68760214 |
| 112 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.68447238 |
| 113 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.68197158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.63956271 |
| 2 | MP0005671_abnormal_response_to | 4.38827597 |
| 3 | MP0001790_abnormal_immune_system | 3.69897769 |
| 4 | MP0005387_immune_system_phenotype | 3.69897769 |
| 5 | MP0001800_abnormal_humoral_immune | 3.68103131 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.55943971 |
| 7 | MP0000685_abnormal_immune_system | 3.18825592 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.06659780 |
| 9 | * MP0002452_abnormal_antigen_presenting | 2.94640492 |
| 10 | MP0002723_abnormal_immune_serum | 2.94435081 |
| 11 | * MP0002420_abnormal_adaptive_immunity | 2.84522475 |
| 12 | * MP0001819_abnormal_immune_cell | 2.82645505 |
| 13 | MP0001873_stomach_inflammation | 2.82444289 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.80636461 |
| 15 | MP0003303_peritoneal_inflammation | 2.76768558 |
| 16 | MP0009785_altered_susceptibility_to | 2.76615719 |
| 17 | MP0005025_abnormal_response_to | 2.69771746 |
| 18 | MP0002398_abnormal_bone_marrow | 2.58771829 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.51037534 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.50337350 |
| 21 | MP0003436_decreased_susceptibility_to | 2.47564730 |
| 22 | MP0006082_CNS_inflammation | 2.43858803 |
| 23 | MP0004510_myositis | 2.42041488 |
| 24 | MP0002006_tumorigenesis | 2.41088510 |
| 25 | * MP0000716_abnormal_immune_system | 2.35695214 |
| 26 | MP0002405_respiratory_system_inflammati | 2.35503328 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 2.32521405 |
| 28 | MP0010155_abnormal_intestine_physiology | 2.25963603 |
| 29 | MP0004947_skin_inflammation | 2.11580940 |
| 30 | * MP0002419_abnormal_innate_immunity | 2.04276453 |
| 31 | MP0000689_abnormal_spleen_morphology | 2.00514297 |
| 32 | MP0003866_abnormal_defecation | 1.98762530 |
| 33 | MP0002722_abnormal_immune_system | 1.97048922 |
| 34 | MP0003045_fibrosis | 1.92931959 |
| 35 | MP0003724_increased_susceptibility_to | 1.92345558 |
| 36 | * MP0002429_abnormal_blood_cell | 1.91397019 |
| 37 | MP0001853_heart_inflammation | 1.89460912 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.84869786 |
| 39 | MP0005310_abnormal_salivary_gland | 1.84757899 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.79759141 |
| 41 | MP0008004_abnormal_stomach_pH | 1.78214698 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.64490117 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.56016399 |
| 44 | MP0002933_joint_inflammation | 1.47395313 |
| 45 | MP0003448_altered_tumor_morphology | 1.44963143 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.27978211 |
| 47 | MP0000858_altered_metastatic_potential | 1.25040949 |
| 48 | MP0008469_abnormal_protein_level | 1.24433741 |
| 49 | MP0000490_abnormal_crypts_of | 1.22457734 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.20966246 |
| 51 | MP0004808_abnormal_hematopoietic_stem | 1.20840537 |
| 52 | MP0005076_abnormal_cell_differentiation | 1.13046958 |
| 53 | MP0010234_abnormal_vibrissa_follicle | 1.11460116 |
| 54 | MP0005174_abnormal_tail_pigmentation | 1.10331469 |
| 55 | MP0008057_abnormal_DNA_replication | 1.08232210 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.07666656 |
| 57 | MP0004381_abnormal_hair_follicle | 1.03783665 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.02620614 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.02620614 |
| 60 | MP0003828_pulmonary_edema | 0.97070636 |
| 61 | MP0002019_abnormal_tumor_incidence | 0.95861952 |
| 62 | MP0002009_preneoplasia | 0.93378765 |
| 63 | MP0001851_eye_inflammation | 0.92887758 |
| 64 | MP0008874_decreased_physiological_sensi | 0.90746749 |
| 65 | MP0010307_abnormal_tumor_latency | 0.90076226 |
| 66 | MP0008961_abnormal_basal_metabolism | 0.87504563 |
| 67 | * MP0002998_abnormal_bone_remodeling | 0.86819697 |
| 68 | MP0009278_abnormal_bone_marrow | 0.85343451 |
| 69 | MP0001663_abnormal_digestive_system | 0.84876810 |
| 70 | MP0005623_abnormal_meninges_morphology | 0.84032148 |
| 71 | MP0005451_abnormal_body_composition | 0.82110957 |
| 72 | MP0003566_abnormal_cell_adhesion | 0.81981242 |
| 73 | MP0008260_abnormal_autophagy | 0.80777582 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 0.79781892 |
| 75 | MP0000343_altered_response_to | 0.78323409 |
| 76 | MP0005166_decreased_susceptibility_to | 0.76371340 |
| 77 | MP0009764_decreased_sensitivity_to | 0.76117590 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 0.75945377 |
| 79 | MP0002822_catalepsy | 0.73899152 |
| 80 | MP0003183_abnormal_peptide_metabolism | 0.73538348 |
| 81 | MP0010352_gastrointestinal_tract_polyps | 0.72470201 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.70089379 |
| 83 | MP0000477_abnormal_intestine_morphology | 0.69877431 |
| 84 | MP0003172_abnormal_lysosome_physiology | 0.68674886 |
| 85 | MP0002136_abnormal_kidney_physiology | 0.67956743 |
| 86 | MP0002163_abnormal_gland_morphology | 0.67206501 |
| 87 | MP0008877_abnormal_DNA_methylation | 0.67099844 |
| 88 | MP0004264_abnormal_extraembryonic_tissu | 0.66757483 |
| 89 | MP0005023_abnormal_wound_healing | 0.66458149 |
| 90 | MP0002693_abnormal_pancreas_physiology | 0.66402944 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.64103201 |
| 92 | MP0003191_abnormal_cellular_cholesterol | 0.63874196 |
| 93 | MP0002168_other_aberrant_phenotype | 0.62621146 |
| 94 | MP0009763_increased_sensitivity_to | 0.62377820 |
| 95 | MP0003878_abnormal_ear_physiology | 0.61193094 |
| 96 | MP0005377_hearing/vestibular/ear_phenot | 0.61193094 |
| 97 | MP0005058_abnormal_lysosome_morphology | 0.60247518 |
| 98 | MP0001191_abnormal_skin_condition | 0.59454771 |
| 99 | MP0008995_early_reproductive_senescence | 0.57342273 |
| 100 | MP0010094_abnormal_chromosome_stability | 0.56930489 |
| 101 | MP0005084_abnormal_gallbladder_morpholo | 0.56625900 |
| 102 | MP0000609_abnormal_liver_physiology | 0.55523138 |
| 103 | MP0009642_abnormal_blood_homeostasis | 0.55456778 |
| 104 | MP0005621_abnormal_cell_physiology | 0.55285638 |
| 105 | MP0009840_abnormal_foam_cell | 0.54891619 |
| 106 | MP0002132_abnormal_respiratory_system | 0.54165749 |
| 107 | MP0000249_abnormal_blood_vessel | 0.53726112 |
| 108 | MP0005167_abnormal_blood-brain_barrier | 0.52250971 |
| 109 | MP0001881_abnormal_mammary_gland | 0.51992194 |
| 110 | MP0001348_abnormal_lacrimal_gland | 0.49767698 |
| 111 | MP0006035_abnormal_mitochondrial_morpho | 0.48424894 |
| 112 | MP0000015_abnormal_ear_pigmentation | 0.47626970 |
| 113 | MP0003075_altered_response_to | 0.47518298 |
| 114 | MP0009115_abnormal_fat_cell | 0.47372615 |
| 115 | MP0003091_abnormal_cell_migration | 0.46989119 |
| 116 | * MP0003795_abnormal_bone_structure | 0.45795546 |
| 117 | MP0005390_skeleton_phenotype | 0.45366219 |
| 118 | MP0005381_digestive/alimentary_phenotyp | 0.44006385 |
| 119 | MP0005083_abnormal_biliary_tract | 0.43835783 |
| 120 | MP0005075_abnormal_melanosome_morpholog | 0.43814259 |
| 121 | MP0001216_abnormal_epidermal_layer | 0.43203678 |
| 122 | MP0000313_abnormal_cell_death | 0.42787918 |
| 123 | MP0004883_abnormal_blood_vessel | 0.42437042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bronchitis (HP:0002837) | 5.92466471 |
| 2 | IgM deficiency (HP:0002850) | 5.64528658 |
| 3 | Menorrhagia (HP:0000132) | 5.45816693 |
| 4 | Increased mean platelet volume (HP:0011877) | 5.24644072 |
| 5 | Epistaxis (HP:0000421) | 5.11026445 |
| 6 | Purpura (HP:0000979) | 5.07813965 |
| 7 | B lymphocytopenia (HP:0010976) | 5.05984007 |
| 8 | Abnormality of B cell number (HP:0010975) | 5.05984007 |
| 9 | Recurrent viral infections (HP:0004429) | 5.00067620 |
| 10 | Agammaglobulinemia (HP:0004432) | 4.72697490 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.69746394 |
| 12 | Nasal polyposis (HP:0100582) | 4.60370401 |
| 13 | Recurrent sinusitis (HP:0011108) | 4.58735477 |
| 14 | Chronic otitis media (HP:0000389) | 4.56382286 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 4.43335920 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.43335920 |
| 17 | Myositis (HP:0100614) | 4.40410687 |
| 18 | Inflammation of the large intestine (HP:0002037) | 4.35257277 |
| 19 | Abnormality of T cell number (HP:0011839) | 4.18704429 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 4.17754040 |
| 21 | Optic neuritis (HP:0100653) | 4.17754040 |
| 22 | Eczematoid dermatitis (HP:0000976) | 4.17547634 |
| 23 | T lymphocytopenia (HP:0005403) | 4.17511608 |
| 24 | Gastrointestinal inflammation (HP:0004386) | 4.11327652 |
| 25 | Meningitis (HP:0001287) | 4.06328926 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.05301286 |
| 27 | Colitis (HP:0002583) | 4.04475495 |
| 28 | Abnormality of T cells (HP:0002843) | 4.00961644 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.98523211 |
| 30 | Recurrent abscess formation (HP:0002722) | 3.86105591 |
| 31 | Vasculitis (HP:0002633) | 3.81015966 |
| 32 | Abnormality of the nasal mucosa (HP:0000433) | 3.80931327 |
| 33 | Orchitis (HP:0100796) | 3.78904937 |
| 34 | Abnormality of T cell physiology (HP:0011840) | 3.76421588 |
| 35 | Pustule (HP:0200039) | 3.69608588 |
| 36 | IgG deficiency (HP:0004315) | 3.58561232 |
| 37 | Gastrointestinal stroma tumor (HP:0100723) | 3.55020016 |
| 38 | Abnormal platelet function (HP:0011869) | 3.53735559 |
| 39 | Impaired platelet aggregation (HP:0003540) | 3.53735559 |
| 40 | IgA deficiency (HP:0002720) | 3.51135842 |
| 41 | Bronchitis (HP:0012387) | 3.44697004 |
| 42 | Chronic diarrhea (HP:0002028) | 3.42946007 |
| 43 | Panhypogammaglobulinemia (HP:0003139) | 3.42758966 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 3.38905799 |
| 45 | Severe combined immunodeficiency (HP:0004430) | 3.38645038 |
| 46 | Cellulitis (HP:0100658) | 3.36439375 |
| 47 | Hyperlipoproteinemia (HP:0010980) | 3.30401047 |
| 48 | Lymphopenia (HP:0001888) | 3.30317962 |
| 49 | Recurrent bacterial skin infections (HP:0005406) | 3.29072502 |
| 50 | Recurrent skin infections (HP:0001581) | 3.24621828 |
| 51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.21881896 |
| 52 | Pulmonary infiltrates (HP:0002113) | 3.19322003 |
| 53 | Combined immunodeficiency (HP:0005387) | 3.19286307 |
| 54 | Increased IgM level (HP:0003496) | 3.15481015 |
| 55 | Obstructive lung disease (HP:0006536) | 3.12874063 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 3.12874063 |
| 57 | Increased IgE level (HP:0003212) | 3.11400946 |
| 58 | Hemoptysis (HP:0002105) | 3.09134016 |
| 59 | Verrucae (HP:0200043) | 3.07910940 |
| 60 | Papilloma (HP:0012740) | 3.07910940 |
| 61 | Autoimmune thrombocytopenia (HP:0001973) | 3.00551232 |
| 62 | Thyroiditis (HP:0100646) | 2.98965841 |
| 63 | Stomatitis (HP:0010280) | 2.96848465 |
| 64 | Chronic sinusitis (HP:0011109) | 2.96793229 |
| 65 | Autoimmune hemolytic anemia (HP:0001890) | 2.85316057 |
| 66 | Recurrent pneumonia (HP:0006532) | 2.83607997 |
| 67 | Arterial thrombosis (HP:0004420) | 2.79893851 |
| 68 | Encephalitis (HP:0002383) | 2.78261359 |
| 69 | Abnormality of the fingertips (HP:0001211) | 2.77099024 |
| 70 | Hypergammaglobulinemia (HP:0010702) | 2.75957803 |
| 71 | Recurrent otitis media (HP:0000403) | 2.69227064 |
| 72 | Cheilitis (HP:0100825) | 2.68673133 |
| 73 | Emphysema (HP:0002097) | 2.67899318 |
| 74 | Keratoconjunctivitis sicca (HP:0001097) | 2.66685398 |
| 75 | Increased density of long bones (HP:0006392) | 2.58223664 |
| 76 | Gastrointestinal infarctions (HP:0005244) | 2.55762836 |
| 77 | Recurrent lower respiratory tract infections (HP:0002783) | 2.54511210 |
| 78 | Abnormality of eosinophils (HP:0001879) | 2.51702056 |
| 79 | Fatigue (HP:0012378) | 2.51540491 |
| 80 | Granulocytopenia (HP:0001913) | 2.48900969 |
| 81 | Arthralgia (HP:0002829) | 2.45000090 |
| 82 | Basal cell carcinoma (HP:0002671) | 2.43869670 |
| 83 | Keratoconjunctivitis (HP:0001096) | 2.42649954 |
| 84 | Hypochromic anemia (HP:0001931) | 2.42460508 |
| 85 | Acute hepatic failure (HP:0006554) | 2.37801388 |
| 86 | Petechiae (HP:0000967) | 2.37356590 |
| 87 | Leukocytosis (HP:0001974) | 2.35130950 |
| 88 | Abnormality of macrophages (HP:0004311) | 2.34525259 |
| 89 | Bronchiectasis (HP:0002110) | 2.32458659 |
| 90 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.30416384 |
| 91 | Restrictive lung disease (HP:0002091) | 2.29870276 |
| 92 | Skin rash (HP:0000988) | 2.29062039 |
| 93 | Joint swelling (HP:0001386) | 2.24781511 |
| 94 | Dyschromatopsia (HP:0007641) | 2.24570355 |
| 95 | Hepatosplenomegaly (HP:0001433) | 2.21793409 |
| 96 | Poikiloderma (HP:0001029) | 2.21248733 |
| 97 | Eosinophilia (HP:0001880) | 2.21055244 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 2.20210309 |
| 99 | Thrombocytosis (HP:0001894) | 2.20024026 |
| 100 | Osteomyelitis (HP:0002754) | 2.19919377 |
| 101 | Pulmonary embolism (HP:0002204) | 2.19005720 |
| 102 | Lymphoma (HP:0002665) | 2.18802564 |
| 103 | Chest pain (HP:0100749) | 2.17833083 |
| 104 | Abnormality of the prostate (HP:0008775) | 2.14723344 |
| 105 | Sepsis (HP:0100806) | 2.14570779 |
| 106 | Urticaria (HP:0001025) | 2.12825436 |
| 107 | Skin ulcer (HP:0200042) | 2.12635532 |
| 108 | Spontaneous hematomas (HP:0007420) | 2.11640567 |
| 109 | Gangrene (HP:0100758) | 2.10389476 |
| 110 | Viral hepatitis (HP:0006562) | 2.08498396 |
| 111 | Abnormality of lateral ventricle (HP:0030047) | 2.08439974 |
| 112 | Abnormal platelet volume (HP:0011876) | 2.07833643 |
| 113 | Hypertensive crisis (HP:0100735) | 2.07360020 |
| 114 | Gingival bleeding (HP:0000225) | 2.06672544 |
| 115 | Gingivitis (HP:0000230) | 2.06591547 |
| 116 | Polyneuropathy (HP:0001271) | 2.05229211 |
| 117 | Abnormality of the common coagulation pathway (HP:0010990) | 2.01376285 |
| 118 | Prolonged bleeding time (HP:0003010) | 2.00941925 |
| 119 | Amaurosis fugax (HP:0100576) | 2.00061265 |
| 120 | Bruising susceptibility (HP:0000978) | 1.99032817 |
| 121 | Pulmonary fibrosis (HP:0002206) | 1.97157282 |
| 122 | Abnormal pupillary function (HP:0007686) | 1.95564940 |
| 123 | Acanthocytosis (HP:0001927) | 1.90946738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 6.43137901 |
| 2 | TXK | 4.90722764 |
| 3 | PRPF4B | 3.91150693 |
| 4 | TYK2 | 3.45446284 |
| 5 | IKBKE | 3.27434431 |
| 6 | JAK3 | 3.23671411 |
| 7 | FGFR4 | 3.20242475 |
| 8 | JAK1 | 2.54110408 |
| 9 | MAP3K14 | 2.50742116 |
| 10 | TBK1 | 2.44716791 |
| 11 | KIT | 2.43675222 |
| 12 | FGFR3 | 2.23371651 |
| 13 | ITK | 2.21527052 |
| 14 | BMPR2 | 2.15374994 |
| 15 | GRK6 | 2.11196219 |
| 16 | IRAK4 | 2.05758481 |
| 17 | ZAP70 | 1.93191154 |
| 18 | STK10 | 1.73385297 |
| 19 | ERN1 | 1.70387797 |
| 20 | SYK | 1.68677384 |
| 21 | BTK | 1.61627265 |
| 22 | IKBKB | 1.57028826 |
| 23 | BLK | 1.55203779 |
| 24 | CSK | 1.54942758 |
| 25 | TAOK3 | 1.54488967 |
| 26 | LCK | 1.54038994 |
| 27 | IRAK3 | 1.51655501 |
| 28 | CSF1R | 1.38290428 |
| 29 | TEC | 1.32619203 |
| 30 | SMG1 | 1.31277677 |
| 31 | EPHB1 | 1.26002572 |
| 32 | SIK2 | 1.24231587 |
| 33 | MAP3K13 | 1.23748731 |
| 34 | PTK2B | 1.23576687 |
| 35 | HCK | 1.22926688 |
| 36 | PIM1 | 1.22146275 |
| 37 | PIM2 | 1.15405725 |
| 38 | MAP3K10 | 1.12199101 |
| 39 | CHUK | 1.07139506 |
| 40 | MST4 | 1.06057816 |
| 41 | LYN | 1.04405428 |
| 42 | FES | 1.04255844 |
| 43 | CDK12 | 1.02117947 |
| 44 | TAOK2 | 1.01483520 |
| 45 | PRKCH | 1.00251233 |
| 46 | JAK2 | 0.99491295 |
| 47 | PASK | 0.97665869 |
| 48 | PRKCQ | 0.94468623 |
| 49 | EIF2AK3 | 0.93811112 |
| 50 | LRRK2 | 0.91441167 |
| 51 | RIPK4 | 0.91110083 |
| 52 | MAPK11 | 0.86669905 |
| 53 | TNK2 | 0.84575698 |
| 54 | NME2 | 0.84555566 |
| 55 | MAPK12 | 0.83854891 |
| 56 | EEF2K | 0.83176970 |
| 57 | TRIB3 | 0.82723309 |
| 58 | CDC42BPA | 0.81491670 |
| 59 | SIK3 | 0.79693740 |
| 60 | TGFBR2 | 0.72492933 |
| 61 | MAP2K3 | 0.72133765 |
| 62 | CDK6 | 0.71303382 |
| 63 | FGR | 0.69630397 |
| 64 | CLK1 | 0.69267070 |
| 65 | PDK1 | 0.68204622 |
| 66 | PIK3CG | 0.67887279 |
| 67 | DMPK | 0.67048978 |
| 68 | TNIK | 0.67029233 |
| 69 | ALK | 0.59951590 |
| 70 | ARAF | 0.58635011 |
| 71 | RIPK1 | 0.56261034 |
| 72 | TESK2 | 0.55954384 |
| 73 | MARK3 | 0.55503080 |
| 74 | MAP3K12 | 0.54102384 |
| 75 | IRAK2 | 0.53838560 |
| 76 | STK24 | 0.53763750 |
| 77 | MAP3K5 | 0.53540773 |
| 78 | TAOK1 | 0.53509152 |
| 79 | RET | 0.52703762 |
| 80 | BMX | 0.52592602 |
| 81 | HIPK2 | 0.52071859 |
| 82 | PRKD2 | 0.51582196 |
| 83 | PDPK1 | 0.51153341 |
| 84 | EIF2AK1 | 0.50628702 |
| 85 | CDK4 | 0.50406603 |
| 86 | CDK9 | 0.50278562 |
| 87 | PTK6 | 0.50076809 |
| 88 | YES1 | 0.48835345 |
| 89 | MATK | 0.48388244 |
| 90 | RAF1 | 0.47779638 |
| 91 | MYLK | 0.47667171 |
| 92 | STK3 | 0.46307092 |
| 93 | NEK2 | 0.45113249 |
| 94 | GRK5 | 0.44605620 |
| 95 | MAPK7 | 0.44068456 |
| 96 | MELK | 0.43679873 |
| 97 | SIK1 | 0.43239153 |
| 98 | EPHA3 | 0.42652440 |
| 99 | ILK | 0.42393775 |
| 100 | NLK | 0.41896310 |
| 101 | ABL1 | 0.41784507 |
| 102 | RPS6KA4 | 0.40178870 |
| 103 | PRKG2 | 0.39051946 |
| 104 | IRAK1 | 0.38239444 |
| 105 | DAPK3 | 0.36757005 |
| 106 | PAK1 | 0.36430227 |
| 107 | INSR | 0.35171882 |
| 108 | EGFR | 0.34659024 |
| 109 | RPS6KA6 | 0.33604760 |
| 110 | FYN | 0.33567236 |
| 111 | TRPM7 | 0.33372749 |
| 112 | PKN2 | 0.32257836 |
| 113 | TYRO3 | 0.31869032 |
| 114 | PRKCI | 0.31641645 |
| 115 | PRKCD | 0.31131102 |
| 116 | ICK | 0.30823531 |
| 117 | NUAK1 | 0.29718935 |
| 118 | KDR | 0.27757159 |
| 119 | TLK1 | 0.27535761 |
| 120 | MAPK3 | 0.27175596 |
| 121 | PKN1 | 0.26296063 |
| 122 | MAP3K8 | 0.26248033 |
| 123 | MAPKAPK3 | 0.26198233 |
| 124 | DAPK1 | 0.25817636 |
| 125 | NEK9 | 0.25330414 |
| 126 | MAPKAPK2 | 0.24993077 |
| 127 | RPS6KC1 | 0.24649993 |
| 128 | RPS6KL1 | 0.24649993 |
| 129 | SGK2 | 0.24497683 |
| 130 | SGK3 | 0.24419460 |
| 131 | RPS6KA5 | 0.23394186 |
| 132 | RPS6KA1 | 0.22359335 |
| 133 | MAP3K11 | 0.22028653 |
| 134 | MAPK4 | 0.21810331 |
| 135 | BRD4 | 0.21635179 |
| 136 | MAP3K7 | 0.20421303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.52134413 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.12163622 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.62598614 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.43611219 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.18457512 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.78890007 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.72668329 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.63287739 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.63240700 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.57504140 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.50775446 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.49937647 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.41068587 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.33140719 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.08598956 |
| 16 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.01957986 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.95830740 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.63003115 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62198662 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.56055134 |
| 21 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.49689208 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.47490878 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47055957 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.46050854 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44118607 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.39853949 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38729429 |
| 28 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.32587555 |
| 29 | Hepatitis B_Homo sapiens_hsa05161 | 1.25866164 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.24287669 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22759740 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.16553628 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.15611769 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13790719 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12095168 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12051831 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.11521453 |
| 38 | Legionellosis_Homo sapiens_hsa05134 | 1.10083525 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.06618671 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.01829257 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92969396 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89641228 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85890463 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.84221078 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 0.82874402 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82014009 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 0.80061035 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79802627 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.78770862 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78568062 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77284443 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.77060259 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76014429 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75780166 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.75169976 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74140334 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.73449280 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71199449 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69265750 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64936844 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63407236 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61724768 |
| 63 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54680971 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54606622 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53869918 |
| 66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51587842 |
| 67 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51525836 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51100992 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50517780 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50449813 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50394954 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50114972 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49903697 |
| 74 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49114713 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47811823 |
| 76 | Ribosome_Homo sapiens_hsa03010 | 0.46670268 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44669607 |
| 78 | Colorectal cancer_Homo sapiens_hsa05210 | 0.43971292 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42989574 |
| 80 | Alcoholism_Homo sapiens_hsa05034 | 0.41442857 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41264792 |
| 82 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40160364 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38608556 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38602225 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34512739 |
| 86 | Gap junction_Homo sapiens_hsa04540 | 0.32956841 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32165192 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31734718 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.30515620 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30241856 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.30065598 |
| 92 | Base excision repair_Homo sapiens_hsa03410 | 0.28841979 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28326641 |
| 94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.28168692 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28058502 |
| 96 | Protein export_Homo sapiens_hsa03060 | 0.27905046 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.27602227 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24448706 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.23977575 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.23315752 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.22884082 |
| 102 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.22878658 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.21741679 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.21127776 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20959837 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20289786 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.20006887 |
| 108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.19663358 |
| 109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.19618660 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.18439630 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.17327458 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.17099059 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.17090198 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | 0.16827599 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.16443480 |
| 116 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15901119 |
| 117 | Lysosome_Homo sapiens_hsa04142 | 0.15157665 |
| 118 | Pathways in cancer_Homo sapiens_hsa05200 | 0.15025223 |
| 119 | Prostate cancer_Homo sapiens_hsa05215 | 0.14911967 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.14701689 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.13541527 |

